SE8303012L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8303012L
SE8303012L SE8303012A SE8303012A SE8303012L SE 8303012 L SE8303012 L SE 8303012L SE 8303012 A SE8303012 A SE 8303012A SE 8303012 A SE8303012 A SE 8303012A SE 8303012 L SE8303012 L SE 8303012L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
cellulose derivative
composition
salbutamol
stimulant
Prior art date
Application number
SE8303012A
Other languages
Unknown language ( )
English (en)
Other versions
SE454946B (sv
SE8303012D0 (sv
Inventor
J M Padfield
C V Groom
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8303012D0 publication Critical patent/SE8303012D0/sv
Publication of SE8303012L publication Critical patent/SE8303012L/sv
Publication of SE454946B publication Critical patent/SE454946B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8303012A 1982-05-27 1983-05-27 Vattendispersion av salbutamol och ett cellulosaderivat SE454946B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215502 1982-05-27

Publications (3)

Publication Number Publication Date
SE8303012D0 SE8303012D0 (sv) 1983-05-27
SE8303012L true SE8303012L (sv) 1983-11-28
SE454946B SE454946B (sv) 1988-06-13

Family

ID=10530673

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303012A SE454946B (sv) 1982-05-27 1983-05-27 Vattendispersion av salbutamol och ett cellulosaderivat

Country Status (25)

Country Link
JP (1) JPH0629181B2 (sv)
AT (1) AT390191B (sv)
AU (1) AU567675B2 (sv)
BE (1) BE896870A (sv)
CA (1) CA1203176A (sv)
CH (1) CH656308A5 (sv)
DE (1) DE3319356C2 (sv)
DK (1) DK167558B1 (sv)
ES (1) ES522752A0 (sv)
FI (1) FI81257C (sv)
FR (1) FR2527442B1 (sv)
GR (1) GR82681B (sv)
IE (1) IE55139B1 (sv)
IL (1) IL68805A0 (sv)
IT (1) IT1174759B (sv)
LU (1) LU84828A1 (sv)
MY (1) MY8700275A (sv)
NL (1) NL192663C (sv)
NO (1) NO163166C (sv)
NZ (1) NZ204385A (sv)
PH (1) PH19601A (sv)
PT (1) PT76773B (sv)
SE (1) SE454946B (sv)
ZA (1) ZA833854B (sv)
ZW (1) ZW11883A1 (sv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624213A (en) * 1963-10-30 1971-11-30 Merck & Co Inc Method of sterilizing aqueous pharmaceutical solutions employing propylene oxide and entrained air
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1453034A (en) * 1972-12-15 1976-10-20 Boehringer Sohn Ingelheim Pharmaceutical composition for treating spasticity
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung

Also Published As

Publication number Publication date
IT1174759B (it) 1987-07-01
DE3319356A1 (de) 1983-12-01
ZA833854B (en) 1985-01-30
NL8301900A (nl) 1983-12-16
NO831875L (no) 1983-11-28
DK241783D0 (da) 1983-05-27
ES8502336A1 (es) 1985-01-01
GR82681B (sv) 1985-02-07
ATA195283A (de) 1989-09-15
NO163166B (no) 1990-01-08
SE454946B (sv) 1988-06-13
IE55139B1 (en) 1990-06-06
NZ204385A (en) 1986-07-11
FI81257B (fi) 1990-06-29
IE831267L (en) 1983-11-27
FR2527442A1 (fr) 1983-12-02
AU567675B2 (en) 1987-12-03
IT8348384A0 (it) 1983-05-27
FR2527442B1 (fr) 1987-07-17
ES522752A0 (es) 1985-01-01
NO163166C (no) 1990-05-02
DK167558B1 (da) 1993-11-22
PT76773A (en) 1983-06-01
IL68805A0 (en) 1983-09-30
CH656308A5 (fr) 1986-06-30
AT390191B (de) 1990-03-26
MY8700275A (en) 1987-12-31
AU1503983A (en) 1983-12-01
PH19601A (en) 1986-05-27
DE3319356C2 (de) 1996-07-04
BE896870A (fr) 1983-11-28
ZW11883A1 (en) 1984-12-19
JPS591411A (ja) 1984-01-06
CA1203176A (en) 1986-04-15
FI831893L (fi) 1983-11-28
FI831893A0 (fi) 1983-05-27
FI81257C (sv) 1990-10-10
SE8303012D0 (sv) 1983-05-27
NL192663C (nl) 1997-12-02
PT76773B (en) 1986-03-27
NL192663B (sv) 1997-08-01
DK241783A (da) 1983-11-28
LU84828A1 (fr) 1985-03-21
JPH0629181B2 (ja) 1994-04-20

Similar Documents

Publication Publication Date Title
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
SE8406081L (sv) Sett och komposition for framstellning av farmaceutiska preparat for oral administrering och med kontrollerad langtidsverkan
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
SE8402549D0 (sv) Substituerade moranolinderivat
SE8300623L (sv) Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
IL83044A (en) Diphenylpropanamines,their preparation and pharmaceutical compositions containing them
DE69429964D1 (de) Feste, therapeutische oder hygienische, mucoadhäsive Zusammensetzung zur Verabreichung durch Auftragen auf der Mund-schleimhaut oder der Nasen-schleimhaut
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
DK140393A (da) Ioderet uracilnicleosid, denne forbindelse til anvendelse mod en adenovirusinfektion, anvendelse af forbindelsen til fremstilling af et lægemiddel mod en adenovirusinfektion, farmaceutisk præparater indeholdende forbindelsen samt fremgangsmåde til fremstilling af forbindelsen
NO870560L (no) Nytt farmasoeytisk preparat.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE8804628D0 (sv) New compounds
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
IT1196041B (it) Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
DK429480A (da) Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
SE8303012L (sv) Farmaceutisk komposition
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
ES2064104T3 (es) Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.
ES2116452T3 (es) Composiciones farmaceuticas que comprenden agonistas de receptores 5ht1 y potenciadores de la absorcion.
ATE15031T1 (de) 1-(2,4-dichlorphenoxy)-3-(3,4-dimethoxy-betaphenethylamino)-2-propanol, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
KR960007619A (ko) 신규 알긴산 유도체 및 그 제조방법
SE8704049D0 (sv) Novel pharmacological compounds

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8303012-2

Format of ref document f/p: F

NUG Patent has lapsed